Last $11.36 USD
Change Today +0.86 / 8.19%
Volume 163.8K
MSON On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

misonix inc (MSON) Snapshot

Open
$10.50
Previous Close
$10.50
Day High
$11.73
Day Low
$10.09
52 Week High
09/19/14 - $11.73
52 Week Low
11/8/13 - $3.86
Market Cap
84.6M
Average Volume 10 Days
83.3K
EPS TTM
$0.14
Shares Outstanding
7.4M
EX-Date
--
P/E TM
81.1x
Dividend
--
Dividend Yield
--
Current Stock Chart for MISONIX INC (MSON)

Related News

No related news articles were found.

misonix inc (MSON) Related Businessweek News

No Related Businessweek News Found

misonix inc (MSON) Details

Misonix, Inc., a surgical device company, designs, develops, manufactures, and markets minimally invasive ultrasonic surgical device products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery, and other surgical applications. The company offers BoneScalpel cutting system that is used for surgical procedures of the spine and in maxillofacial procedures; SonaStar surgical aspirator, which is used to emulsify and remove soft and hard tumors; and SonicOne wound cleansing and debridement system for the removal of devitalized tissue and fibrin deposits while sparing viable cells. It also markets AutoSonix ultrasound cutting and coagulating system that is used for various laparoscopic surgical procedures. The company sells its products through direct sales persons, sales agents, and distributors. It has operations in the United States, Australia, Europe, Asia, Canada, Mexico, South America, South Africa, and the Middle East. The company was founded in 1959 and is based in Farmingdale, New York.

68 Employees
Last Reported Date: 09/17/14
Founded in 1959

misonix inc (MSON) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $388.9K
Chief Financial Officer, Senior Vice Presiden...
Total Annual Compensation: $244.5K
Vice President of Research & Development and ...
Total Annual Compensation: $176.0K
Vice President of Global Sales and Marketing
Total Annual Compensation: $203.0K
Compensation as of Fiscal Year 2014.

misonix inc (MSON) Key Developments

Misonix Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended June 30, 2014

Misonix Inc. reported unaudited consolidated earnings results for the fourth quarter and year ended June 30, 2014. For the quarter, the company reported net sales of $5,578,147 compared to $3,758,983 a year ago. The increase was attributable to a 65% increase in BoneScalpel revenue to $2.5 million, a 75% increase in SonaStar revenue to $2.4 million and a 15% increase in SonicOne revenue to $494,000. Income from operations was $234,238 compared to loss from operations of $2,230,995 a year ago. Income from continuing operations before income taxes was $1,404,154 compared to loss from continuing operations of $1,547,581 a year ago. Net income from continuing operations was $1,387,400 or $0.18 per diluted share compared to net loss from continuing operations of $1,527,682 or $0.22 per diluted share a year ago. Net income was $1,389,193 or $0.18 per diluted share compared to net loss of $1,533,700 or $0.22 per diluted share a year ago. For the year, the company reported net sales of $17,060,435 compared to $14,827,226 a year ago principally attributable to an increase of 21% in BoneScalpel revenue to $7.7 million, a 20% increase in SonaStar revenue to $6.3 million and a 20% increase in SonicOne revenue to $2.2 million. Loss from operations was $2,548,964 compared to $5,318,772 a year ago. Income from continuing operations before income taxes was $1,157,210 compared to loss from continuing operations of $2,921,943 a year ago. Net income from continuing operations was $1,126,580 or $0.15 per diluted share compared to net loss from continuing operations of $2,846,747 or $0.40 per diluted share a year ago. Net income was $1,393,299 or $0.19 per diluted share compared to net loss of $2,670,965 or $0.38 per diluted share a year ago.

Misonix Inc. to Report Q4, 2014 Results on Sep 10, 2014

Misonix Inc. announced that they will report Q4, 2014 results at 8:05 PM, US Eastern Standard Time on Sep 10, 2014

Misonix Inc., Q4 2014 Earnings Call, Sep 10, 2014

Misonix Inc., Q4 2014 Earnings Call, Sep 10, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MSON:US $11.36 USD +0.86

MSON Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Integra LifeSciences Holdings Corp $49.76 USD -0.73
Johnson & Johnson $107.99 USD +0.64
Smith & Nephew PLC 1,066 GBp -2.00
Stryker Corp $82.84 USD -1.23
View Industry Companies
 

Industry Analysis

MSON

Industry Average

Valuation MSON Industry Range
Price/Earnings 75.3x
Price/Sales 4.9x
Price/Book 5.1x
Price/Cash Flow 60.7x
TEV/Sales 4.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MISONIX INC, please visit www.misonix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.